Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Hospira, Inc. | Rocky Mount, NC, United States | Makes it, tests it, packages it and labels it | No problems foundFeb 7, 2025 · 11 inspections, 3 with FDA action |
| Hospira Worldwide, LLC | Pleasant Prairie, WI, United States | Tests it | No problems foundDec 16, 2025 · 5 inspections |
Recalls
- Jun 15, 2017 · Class II · Hospira a Pfizer Company
Lack of Sterility Assurance
Lots: a.) one vial Lot: 74393EV Exp. 05/01/2018 Lot: 75157EV Exp. 06/01/2018 Lot: 75367EV, Exp. 06/01/2018 b.) 25 vial carton Lot: 75158EV; Exp. 06/01/2018 - Mar 15, 2016 · Class III · Hospira Inc.
Labeling: Incorrect or Missing Lot and/or Exp Date: Potential for the lot number and/or expiration date to be faded or missing from the primary label on the glass vial.
Lots: Lot 52-045-EV, Exp 07/1/2016 - Feb 26, 2013 · Class II · Hospira Inc.
Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.
Lots: Lot 21-480-EV Exp.12/13
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Succinylcholine: every company that makes it
- Form
- injection, solution, intramuscular; intravenous
- Strength
- 20 mg per 1 mL
- Approval
- NDA NDA008845
- On the market since
- Apr 30, 2005
- Package NDCs
0409-6629-020409-6629-12- Official label
- DailyMed (National Library of Medicine), updated Aug 18, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?